NCT01010646
Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4
Phase: Phase 2
Role: Collaborator
Start: Mar 31, 2010
Completion: Nov 30, 2013